Literature DB >> 22142693

Fumonisin B1 and risk of hepatocellular carcinoma in two Chinese cohorts.

E Christina Persson1, Vikash Sewram, Alison A Evans, W Thomas London, Yvette Volkwyn, Yen-Ju Shen, Jacobus A Van Zyl, Gang Chen, Wenyao Lin, Gordon S Shephard, Philip R Taylor, Jin-Hu Fan, Sanford M Dawsey, You-Lin Qiao, Katherine A McGlynn, Christian C Abnet.   

Abstract

Fumonisin B1 (FB1), a mycotoxin that contaminates corn in certain climates, has been demonstrated to cause hepatocellular cancer (HCC) in animal models. Whether a relationship between FB1 and HCC exists in humans is not known. To examine the hypothesis, we conducted case-control studies nested within two large cohorts in China; the Haimen City Cohort and the General Population Study of the Nutritional Intervention Trials cohort in Linxian. In the Haimen City Cohort, nail FB1 levels were determined in 271 HCC cases and 280 controls. In the General Population Nutritional Intervention Trial, nail FB1 levels were determined in 72 HCC cases and 147 controls. In each population, odds ratios and 95% confidence intervals (95%CI) from logistic regression models estimated the association between measurable FB1 and HCC, adjusting for hepatitis B virus infection and other factors. A meta-analysis that included both populations was also conducted. The analysis revealed no statistically significant association between FB1 and HCC in either Haimen City (OR=1.10, 95%CI=0.64-1.89) or in Linxian (OR=1.47, 95%CI=0.70-3.07). Similarly, the pooled meta-analysis showed no statistically significant association between FB1 exposure and HCC (OR=1.22, 95%CI=0.79-1.89). These findings, although somewhat preliminary, do not support an associated between FB1 and HCC. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142693      PMCID: PMC3299856          DOI: 10.1016/j.fct.2011.11.029

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  32 in total

Review 1.  Testing hair for pharmaceuticals.

Authors:  Y Gaillard; G Pépin
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-10-15

2.  Tissue sphinganine as a biomarker of fumonisin-induced apoptosis.

Authors:  R R Delongchamp; J F Young
Journal:  Food Addit Contam       Date:  2001-03

3.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

4.  Co-contamination of aflatoxin B1 and fumonisin B1 in food and human dietary exposure in three areas of China.

Authors:  G Sun; S Wang; X Hu; J Su; Y Zhang; Y Xie; H Zhang; L Tang; J-S Wang
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-01-18

5.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

Review 6.  Biomarkers of exposure to fumonisin mycotoxins: a review.

Authors:  G S Shephard; L Van Der Westhuizen; V Sewram
Journal:  Food Addit Contam       Date:  2007-10

7.  Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay.

Authors:  W C A Gelderblom; W F O Marasas; S Lebepe-Mazur; S Swanevelder; S Abel
Journal:  Toxicology       Date:  2008-06-20       Impact factor: 4.221

8.  Occurrence of fumonisin B(1) in corn from the main corn-producing areas of China.

Authors:  Hui-Zhi Gong; Rong Ji; Yan-Xi Li; Hong-Yu Zhang; Bing Li; Yue Zhao; Lin Sun; Fei Yu; Jun Yang
Journal:  Mycopathologia       Date:  2008-07-18       Impact factor: 2.574

9.  Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China.

Authors:  Chen-Xu Qu; Farin Kamangar; Jin-Hu Fan; Binbing Yu; Xiu-Di Sun; Philip R Taylor; Bingshu E Chen; Christian C Abnet; You-Lin Qiao; Steven D Mark; Sanford M Dawsey
Journal:  J Natl Cancer Inst       Date:  2007-08-08       Impact factor: 13.506

Review 10.  A review of the toxic effects and mechanisms of action of fumonisin B1.

Authors:  H Stockmann-Juvala; K Savolainen
Journal:  Hum Exp Toxicol       Date:  2008-11       Impact factor: 2.903

View more
  5 in total

Review 1.  Mycotoxin-Linked Mutations and Cancer Risk: A Global Health Issue.

Authors:  Theodora Ekwomadu; Mulunda Mwanza; Alfred Musekiwa
Journal:  Int J Environ Res Public Health       Date:  2022-06-24       Impact factor: 4.614

2.  Providing Biological Plausibility for Exposure-Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework.

Authors:  Annick D van den Brand; Lola Bajard; Inger-Lise Steffensen; Anne Lise Brantsæter; Hubert A A M Dirven; Jochem Louisse; Ad Peijnenburg; Sophie Ndaw; Alberto Mantovani; Barbara De Santis; Marcel J B Mengelers
Journal:  Toxins (Basel)       Date:  2022-04-13       Impact factor: 5.075

Review 3.  Review of the inhibition of biological activities of food-related selected toxins by natural compounds.

Authors:  Mendel Friedman; Reuven Rasooly
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

Review 4.  Research Progress on Fumonisin B1 Contamination and Toxicity: A Review.

Authors:  Jia Chen; Jun Wen; Yating Tang; Jichao Shi; Guodong Mu; Rong Yan; Jing Cai; Miao Long
Journal:  Molecules       Date:  2021-08-29       Impact factor: 4.411

Review 5.  Mycotoxins' Toxicological Mechanisms Involving Humans, Livestock and Their Associated Health Concerns: A Review.

Authors:  Chinaza Godseill Awuchi; Erick Nyakundi Ondari; Sarah Nwozo; Grace Akinyi Odongo; Ifie Josiah Eseoghene; Hannington Twinomuhwezi; Chukwuka U Ogbonna; Anjani K Upadhyay; Ademiku O Adeleye; Charles Odilichukwu R Okpala
Journal:  Toxins (Basel)       Date:  2022-02-24       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.